These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22073388)

  • 21. [On application of antipsychotic drugs].
    Shimizu M
    No To Shinkei; 1994 Mar; 46(3):209-14. PubMed ID: 7910750
    [No Abstract]   [Full Text] [Related]  

  • 22. [Vitamin B6 add-on therapy in treatment of schizophrenic patients with psychotic symptoms and movement disorders].
    Miodownik C; Cohen H; Kotler M; Lerner V
    Harefuah; 2003 Sep; 142(8-9):592-6, 647. PubMed ID: 14518160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A quantitative measure of handwriting dysfluency for assessing tardive dyskinesia.
    Caligiuri MP; Teulings HL; Dean CE; Lohr JB
    J Clin Psychopharmacol; 2015 Apr; 35(2):168-74. PubMed ID: 25679121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Motor disturbances in psychosis].
    Putzhammer A; Hajak G
    Psychiatr Prax; 2005 Apr; 32 Suppl 1():S1-2. PubMed ID: 15818514
    [No Abstract]   [Full Text] [Related]  

  • 25. The emerging role of clozapine in the treatment of movement disorders.
    Factor SA; Friedman JH
    Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin in the treatment of orofacial tardive dyskinesia: a single blind study.
    Slotema CW; van Harten PN; Bruggeman R; Hoek HW
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):507-9. PubMed ID: 18022743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine-induced tardive dystonia: a case report.
    Gnanavel S; Thanapal S; Khandelwal SK; Sood M
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E24-5. PubMed ID: 24763779
    [No Abstract]   [Full Text] [Related]  

  • 28. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to low-dose quetiapine.
    Walsh RA; Lang AE
    Mov Disord; 2011 Oct; 26(12):2297-8. PubMed ID: 21735479
    [No Abstract]   [Full Text] [Related]  

  • 30. Epidemiology of tardive dyskinesia Part I.
    Pineau R; Lachance R; Pelchat G; Jus K; Pires P; Pires P; Villenueve
    Dis Nerv Syst; 1976 Apr; 37(4):210-4. PubMed ID: 3394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid improvement of neuroleptic-induced tardive dyskinesia with levetiracetam in an interictal psychotic patient.
    Chen PH; Liu HC
    J Clin Psychopharmacol; 2010 Apr; 30(2):205-7. PubMed ID: 20520300
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacologic management of psychosis in the elderly.
    Sable JA; Jeste DV
    J Nutr Health Aging; 2003; 7(6):421-7. PubMed ID: 14625622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tardive dyskinesia occurring in a young woman after withdrawal of an atypical antipsychotic drug.
    Alblowi MA; Alosaimi FD
    Neurosciences (Riyadh); 2015 Oct; 20(4):376-9. PubMed ID: 26492119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olanzapine in the management of psychosis in Huntington’s disease: a case report.
    Huarcaya-Victoria J; Plasencia-Yasuda R; Ñique-Rivas M; Suárez-Agreda K; Cerrato-Huayaney J
    Actas Esp Psiquiatr; 2019 Sep; 47(5):202-8. PubMed ID: 31648344
    [No Abstract]   [Full Text] [Related]  

  • 36. [Tardive dyskinesia: diagnosis, assessment and treatment].
    Frascarelli M; Paolemili M; Gallo M; Parente F; Biondi M
    Riv Psichiatr; 2013; 48(3):187-96. PubMed ID: 23752802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic drug binding in the substantia nigra: an examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia.
    Chen S; Seeman P; Liu F
    Synapse; 2011 Feb; 65(2):119-24. PubMed ID: 20524177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of tardive dystonia with clozapine.
    Adityanjee ; Estrera AB
    Biol Psychiatry; 1996 Jun; 39(12):1064-5. PubMed ID: 8780846
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of tardive dyskinesia with thiopropazate.
    Curran JP
    Am J Psychiatry; 1973 Aug; 130(8):925-7. PubMed ID: 4146097
    [No Abstract]   [Full Text] [Related]  

  • 40. A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis.
    Fallon P; Dursun SM
    J Psychopharmacol; 2011 Jun; 25(6):755-62. PubMed ID: 20147573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.